Latest RFP From Kazakh

Drugs with the Active Substance Aripiprazole (Atc: N05ax12 - for Parenteral Administration)

Bidding for Gear Shifting Devices, Dhj 2023-2027

Open House Discount Drug Contracts for Betamethasone and Fusidic Acid, Atc D07cc01

Medicines Containing the Active Substance Zolmitriptan (Atc: N02cc03)

Medicines Containing the Active Ingredient Fulvestrant (Atc: L02ba03)

Open House Drug Discount Contracts Ibuprofen, Prescription, in Immediate-Release Dosage Form with the Potency 400Mg and 600Mg, Atc M01ae01

Open House Drug Discount Agreements Cinacalcet, Atc H05bx01

Open House Drug Discount Agreements Certolizumab Pegol, Atc L04ab05

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Metoprolol and Hydrochlorothiazide (C07bb22) as Part of a House Model.